{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T14:56:08Z","timestamp":1787928968492,"version":"build-2784847793"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.ejca.2023.03.028","type":"journal-article","created":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T15:28:22Z","timestamp":1680276502000},"page":"105-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["European Society of Breast Cancer Specialists\/Advanced Breast Cancer Global Alliance quality indicators for metastatic breast cancer care"],"prefix":"10.1016","volume":"187","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6692-2249","authenticated-orcid":false,"given":"Fatima","family":"Cardoso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0411-0736","authenticated-orcid":false,"given":"Amelia","family":"McCartney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Ponti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenza","family":"Marotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4412-0891","authenticated-orcid":false,"given":"Conny","family":"Vrieling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6666-5599","authenticated-orcid":false,"given":"Alexandru","family":"Eniu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berta","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Ripamonti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3509-3035","authenticated-orcid":false,"given":"Luzia","family":"Travado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Spitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Jolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1781-2518","authenticated-orcid":false,"given":"Giuseppe","family":"Curigliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4279-5492","authenticated-orcid":false,"given":"Frederique","family":"Penault-Llorca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Lecouvet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel T.","family":"Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7989-8658","authenticated-orcid":false,"given":"Laura","family":"Biganzoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2023.03.028_bib1","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1016\/S0959-8049(00)00180-5","article-title":"The requirements of a specialist breast unit","volume":"36","year":"2000","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2023.03.028_bib2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejca.2017.08.017","article-title":"Quality indicators in breast cancer care: an update from the EUSOMA working group","volume":"86","author":"Biganzoli","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2023.03.028_bib3","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ejca.2016.10.023","article-title":"European Breast Cancer Conference manifesto on breast centres\/units","volume":"72","author":"Cardoso","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2023.03.028_bib4","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"7193","author":"Sung","year":"2021","journal-title":"CA: Cancer J Clin"},{"issue":"11","key":"10.1016\/j.ejca.2023.03.028_bib5","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/S1470-2045(21)00462-9","article-title":"National health system characteristics, breast cancer stage at diagnosis, and breast cancer mortality: a population-based analysis","volume":"22","author":"Duggan","year":"2021","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2023.03.028_bib6","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41572-019-0111-2","article-title":"Breast cancer","volume":"5","author":"Harbeck","year":"2019","journal-title":"Nat Rev Dis Primers"},{"issue":"12","key":"10.1016\/j.ejca.2023.03.028_bib7","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.annonc.2020.09.010","article-title":"5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)","volume":"31","author":"Cardoso","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2023.03.028_bib8","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.breast.2017.05.014","article-title":"Palliative systemic therapy and overall survival of 1,395 patients with advanced breast cancer \u2013 results from the prospective German TMK cohort study","volume":"34","author":"Fietz","year":"2017","journal-title":"Breast"},{"key":"10.1016\/j.ejca.2023.03.028_bib9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejca.2018.03.015","article-title":"Time trends of overall survival among metastatic breast cancer patients in the real-life ESME cohort","volume":"96","author":"Gobbini","year":"2018","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2023.03.028_bib10","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ejca.2020.01.016","article-title":"Contemporary outcomes of metastatic breast cancer among 22,000 women from the multicentre ESME cohort 2008-2016","volume":"129","author":"Deluche","year":"2020","journal-title":"Eur J Cancer"},{"issue":"16_suppl","key":"10.1016\/j.ejca.2023.03.028_bib11","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1200\/JCO.2022.40.16_suppl.1008","article-title":"Contributions of screening, early-stage treatment, and metastatic treatment to breast cancer mortality reduction by molecular subtype in U.S. women, 2000-2017","volume":"40","author":"Caswell-Jin","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2023.03.028_bib12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.breast.2020.02.003","article-title":"The requirements of a specialist breast centre","volume":"51","author":"Biganzoli","year":"2020","journal-title":"Breast"},{"issue":"12","key":"10.1016\/j.ejca.2023.03.028_bib13","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.annonc.2021.09.019","article-title":"ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer","volume":"32","author":"Gennari","year":"2021","journal-title":"Ann Oncol"},{"issue":"35","key":"10.1016\/j.ejca.2023.03.028_bib14","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1200\/JCO.21.01392","article-title":"Endocrine treatment and targeted therapy for hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer: ASCO guideline update","volume":"39","author":"Burstein","year":"2021","journal-title":"J Clin Oncol"},{"issue":"23","key":"10.1016\/j.ejca.2023.03.028_bib15","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1200\/JCO.22.00519","article-title":"Systemic therapy for advanced human epidermal growth factor receptor 2-positive breast cancer: ASCO guideline update","volume":"40","author":"Giordano","year":"2022","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.ejca.2023.03.028_bib16","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJM199002223220802","article-title":"A randomized trial of surgery in the treatment of single metastases to the brain","volume":"322","author":"Patchell","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2023.03.028_bib17","first-page":"1049","article-title":"Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C\/CEC\u00b73): a multicentre, randomised, controlled, phase 3 trial","volume":"18","author":"Brown","year":"2017"},{"issue":"8","key":"10.1016\/j.ejca.2023.03.028_bib18","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/S1470-2045(17)30414-X","article-title":"Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial","volume":"18","author":"Mahajan","year":"2017","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2023.03.028_bib19","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1470-2045(14)70061-0","article-title":"Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study","volume":"15","author":"Yamamoto","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2023.03.028_bib20","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJMoa1000678","article-title":"Early palliative care for patients with metastatic non-small-cell lung cancer","volume":"363","author":"Temel","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2023.03.028_bib21","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1200\/JCO.2014.58.6362","article-title":"Early versus delayed initiation of concurrent palliative oncology care: patient outcomes in the ENABLE III randomized controlled trial","volume":"33","author":"Bakitas","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2023.03.028_bib22","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1200\/JCO.2014.58.7824","article-title":"Benefits of early versus delayed palliative care to informal family caregivers of patients with advanced cancer: outcomes from the ENABLE III randomized controlled trial","volume":"33","author":"Dionne-Odom","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2023.03.028_bib23","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1200\/JCO.2011.35.7996","article-title":"Effect of early palliative care on chemotherapy use and end-of-life care in patients with metastatic non\u2013small-cell lung cancer","volume":"30","author":"Greer","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2023.03.028_bib24","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ejca.2019.11.009","article-title":"The effect of early and systematic integration of palliative care in oncology on quality of life and health care use near the end of life: a randomised controlled trial","volume":"124","author":"Vanbutsele","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2023.03.028_bib25","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1200\/JCO.2016.70.1474","article-title":"Integration of palliative care into standard oncology care: American Society of Clinical Oncology Clinical Practice Guideline Update","volume":"35","author":"Ferrell","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2023.03.028_bib26","unstructured":"National Comprehensive Cancer Network. NCCN guidelines version 2.2023: distress management. \u3008https:\/\/www.nccn.org\/professionals\/physician_gls\/default.aspx\u3009."},{"issue":"9","key":"10.1016\/j.ejca.2023.03.028_bib27","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.annonc.2022.04.007","article-title":"The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guidelines","volume":"33","author":"Di Maio","year":"2022","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2023.03.028_bib28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.6004\/jnccn.2021.0001","article-title":"Genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN Clinical Practice Guidelines in Oncology","volume":"19","author":"Daly","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"issue":"6","key":"10.1016\/j.ejca.2023.03.028_bib29","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.annonc.2020.03.284","article-title":"ESO-ESMO 4rd International Consensus Guidelines for Breast Cancer in Young Women (BCY4)","volume":"31","author":"Paluch-Shimon","year":"2020","journal-title":"Ann Oncol"},{"issue":"Supplement 5","key":"10.1016\/j.ejca.2023.03.028_bib30","doi-asserted-by":"crossref","first-page":"v103","DOI":"10.1093\/annonc\/mdw327","article-title":"Prevention and screening in BRCA mutation carriers and other breast\/ovarian hereditary cancer syndromes: ESMO clinical practice guidelines for cancer prevention and screening","volume":"27","author":"Paluch-Shimon","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2023.03.028_bib31","first-page":"69","article-title":"Progression-free survival\/time to progression as a potential surrogate for overall survival in HR+, HER2- metastatic breast cancer","volume":"10","author":"Forsythe","year":"2018","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"10.1016\/j.ejca.2023.03.028_bib32","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ejca.2018.11.012","article-title":"A systematic review of trial-level meta-analyses measuring the strength of association between surrogate end-points and overall survival in oncology","volume":"106","author":"Haslam","year":"2019","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2023.03.028_bib33","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.breast.2022.07.006","article-title":"Progression-free survival and quality of life in metastatic breast cancer: the patient perspective","volume":"65","author":"Mertz","year":"2022","journal-title":"Breast"},{"issue":"8","key":"10.1016\/j.ejca.2023.03.028_bib34","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1001\/jamainternmed.2015.2829","article-title":"The strength of\u00a0association between surrogate end points and survival in oncology. A systematic review of trial-level meta-analyses","volume":"175","author":"Prasad","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ejca.2023.03.028_bib35","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrclinonc.2011.156","article-title":"The value of progression-free survival to patients with advanced-stage cancer","volume":"9","author":"Fallowfield","year":"2012","journal-title":"Nat Rev Clin Oncol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804923001648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804923001648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:41:21Z","timestamp":1760733681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804923001648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":35,"alternative-id":["S0959804923001648"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2023.03.028","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"European Society of Breast Cancer Specialists\/Advanced Breast Cancer Global Alliance quality indicators for metastatic breast cancer care","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2023.03.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}